Review: Comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging

Clinical Physiology and Functional Imaging

Volumn 34, Issue 3, 2014, Pages 163-170

  Ghotbi, Adam A ^a   Kjær, Andreas ^a   Hasbak, Philip ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cardiac PET; Cardiac SPECT; Cardiology; Myocardial perfusion imaging; Rubidium

Indexed keywords

RUBIDIUM 82; RUBIDIUM;

COMPUTER PROGRAM; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; CYCLOTRON; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOSIMETRY; ECONOMIC ASPECT; GAMMA CAMERA; GENERATOR; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MYOCARDIAL PERFUSION IMAGING; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC USE; HEART DISEASE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; SCINTISCANNING;

CORONARY CIRCULATION; HEART DISEASES; HUMANS; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RUBIDIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84898598583     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/cpf.12083     Document Type: Review

References (64)

1. Aarnoudse WH, Botman KJ, Pijls NH. False-negative myocardial scintigraphy in balanced three-vessel disease, revealed by coronary pressure measurement. Int J Cardiovasc Intervent (2003); 5: 67-71.
2. Alexanderson E, Jacome R, Jimenez-Santos M, Ochoa JM, Romero E, Cabral MA, Ricalde A, Inarra F, Meave A, Alexanderson G. Evaluation of the endothelial function in hypertensive patients with 13N-ammonia PET. J Nucl Cardiol (2012); 19: 979-986.
3. Bateman TM. Advantages and disadvantages of PET and SPECT in a busy clinical practice. J Nucl Cardiol (2012); 19(Suppl 1): S3-S11.
4. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med (2007); 356: 830-840.
5. Clarke EA, Notghi A, Harding LK. Are MIBI/tetrofosmin heart studies a potential radiation hazard to technologists? Nucl Med Commun (1997); 18: 574-577.
6. Davidson G, Tout D, Hurley C, Bartley M, Bradley A, Tonge C, Arumugam P. Comparative evaluation of staff dose from myocardial perfusion imaging using 82Rb PET-CT and 99mTc SPECT-CT. Eur J Nucl Med Mol Imaging (2011); 38(Suppl 2): 93-228.
7. Di Carli MF, Lipton MJ. Cardiac Pet and PET/CT Imaging (2007). Springer Science+Business Media LLC, New York.
8. Di Carli MF, Dorbala S, Curillova Z, Kwong RJ, Goldhaber SZ, Rybicki FJ, Hachamovitch R. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol (2007a); 14: 799-809.
9. Di Carli MF, Dorbala S, Meserve J, El Fakhri G, Sitek A, Moore SC. Clinical myocardial perfusion PET/CT. J Nucl Med (2007b); 48: 783-793.
10. Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. J Nucl Med (2007); 48: 349-358.
11. Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, Chow BJ, Min JK, Pencina MJ, Berman DS, Shaw LJ. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol (2013); 61: 176-184.
12. El Fakhri G, Kardan A, Sitek A, Dorbala S, Abi-Hatem N, Lahoud Y, Fischman A, Coughlan M, Yasuda T, Di Carli MF. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET. J Nucl Med (2009); 50: 1062-1071.
13. Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O'Brien HA Jr. Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med (1983); 24: 907-915.
14. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol (2004); 43: 200-208.
15. Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, Burkhard N, Wyss CA, Kaufmann PA. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol (2009); 54: 150-156.
16. Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, Edenbrandt L, Flotats A, Germano G, Stopar TG, Franken P, Kelion A, Kjaer A, Le Guludec D, Ljungberg M, Maenhout AF, Marcassa C, Marving J, McKiddie F, Schaefer WM, Stegger L, Underwood R. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging (2008); 35: 851-885.
17. Hsiao EM, Ali B, Dorbala S. Clinical role of hybrid imaging. Curr Cardiovasc Imaging Rep (2010); 3: 324-335.
18. Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester HJ, Ziegler SI, Casebier DS, Robinson SP, Schwaiger M. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med (2008); 49: 630-636.
19. Ito Y, Katoh C, Noriyasu K, Kuge Y, Furuyama H, Morita K, Kohya T, Kitabatake A, Tamaki N. Estimation of myocardial blood flow and myocardial flow reserve by 99mTc-sestamibi imaging: comparison with the results of [15O]H2O PET. Eur J Nucl Med Mol Imaging (2003); 30: 281-287.
20. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Luscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation (2000); 102: 1233-1238.
21. deKemp RA, Yoshinaga K, Beanlands RS. Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? J Nucl Cardiol (2007); 14: 380-397.
22. Kjaer A, Cortsen A, Rahbek B, Hasseldam H, Hesse B. Attenuation and scatter correction in myocardial SPET: improved diagnostic accuracy in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging (2002); 29: 1438-1442.
23. Kjaer A, Meyer C, Nielsen FS, Parving HH, Hesse B. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes. J Nucl Med (2003); 44: 19-23.
24. Kjaer A, Meyer C, Wachtell K, Olsen MH, Ibsen H, Opie L, Holm S, Hesse B. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy. Am J Cardiol (2005); 96: 1692-1698.
25. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO Jr, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation (2003); 108: 1404-1418.
26. Kristoffersen US, Wiinberg N, Petersen CL, Gerstoft J, Gutte H, Lebech AM, Kjaer A. Reduction in coronary and peripheral vasomotor function in patients with HIV after initiation of antiretroviral therapy: a longitudinal study with positron emission tomography and flow-mediated dilation. Nucl Med Commun (2010); 31: 874-880.
27. Kuhle WG, Porenta G, Huang SC, Buxton D, Gambhir SS, Hansen H, Phelps ME, Schelbert HR. Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation (1992); 86: 1004-1017.
28. Lima RS, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA, Samady H. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol (2003); 42: 64-70.
29. Lin JW, Laine AF, Akinboboye O, Bergmann SR. Use of wavelet transforms in analysis of time-activity data from cardiac PET. J Nucl Med (2001a); 42: 194-200.
30. Lin JW, Laine AF, Bergmann SR. Improving PET-based physiological quantification through methods of wavelet denoising. IEEE Trans Bio-med Eng (2001b); 48: 202-212.
31. Madar I, Ravert HT, Du Y, Hilton J, Volokh L, Dannals RF, Frost JJ, Hare JM. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med (2006); 47: 1359-1366.
32. Marcassa C, Bax JJ, Bengel F, Hesse B, Petersen CL, Reyes E, Underwood R. Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. Eur Heart J (2008); 29: 557-563.
33. Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. J Am Coll Cardiol (2012); 60: 1828-1837.
34. Merhige ME, Breen WJ, Shelton V, Houston T, D'Arcy BJ, Perna AF. Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med (2007); 48: 1069-1076.
35. Mullani NA, Goldstein RA, Gould KL, Marani SK, Fisher DJ, O'Brien HA Jr, Loberg MD. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med (1983); 24: 898-906.
36. Muzik O, Beanlands RS, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med (1993); 34: 83-91.
37. Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol (2004); 11: 551-561.
38. Naya M, Murthy VL, Foster CR, Gaber M, Klein J, Hainer J, Dorbala S, Blankstein R, Di Carli MF. Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease. J Am Coll Cardiol (2013); 61: 2098-2106.
39. Nitzsche EU, Choi Y, Czernin J, Hoh CK, Huang SC, Schelbert HR. Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation (1996); 93: 2000-2006.
40. Parkash R, deKemp RA, Ruddy TD, Kitsikis A, Hart R, Beauchesne L, Williams K, Davies RA, Labinaz M, Beanlands RS. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol (2004); 11: 440-449.
41. Prior JO, Allenbach G, Valenta I, Kosinski M, Burger C, Verdun FR, Bischof Delaloye A, Kaufmann PA. Quantification of myocardial blood flow with 82Rb positron emission tomography: clinical validation with 15O-water. Eur J Nucl Med Mol Imaging (2012); 39: 1037-1047.
42. Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun (2008); 29: 193-207.
43. Rigo P, Van Boxem P, Foulon J, Safi M, Engdahl J, Links J. Quantitative evaluation of a comprehensive motion, resolution, and attenuation correction program: initial experience. J Nucl Cardiol (1998); 5: 458-468.
44. Schelbert HR, Phelps ME, Hoffman EJ, Huang SC, Selin CE, Kuhl DE. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol (1979); 43: 209-218.
45. Schelbert HR, Phelps ME, Huang SC, MacDonald NS, Hansen H, Selin C, Kuhl DE. N-13 ammonia as an indicator of myocardial blood flow. Circulation (1981); 63: 1259-1272.
46. Schelbert HR, Wisenberg G, Phelps ME, Gould KL, Henze E, Hoffman EJ, Gomes A, Kuhl DE. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol (1982); 49: 1197-1207.
47. Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong RY, Di Carli MF. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation (2008); 117: 1693-1700.
48. Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang XL, Sayre J, Dahlbom M, Licinio J, Schelbert HR. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol (2006); 47: 1188-1195.
49. Schindler TH, Facta AD, Prior JO, Cadenas J, Zhang XL, Li Y, Sayre J, Goldin J, Schelbert HR. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus. Eur J Nucl Med Mol Imaging (2009); 36: 219-229.
50. Schleipman AR, Castronovo FP Jr, Di Carli MF, Dorbala S. Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging. J Nucl Cardiol (2006); 13: 378-384.
51. Schuijf JD, Wijns W, Jukema JW, Atsma DE, de Roos A, Lamb HJ, Stokkel MP, Dibbets-Schneider P, Decramer I, De Bondt P, van der Wall EE, Vanhoenacker PK, Bax JJ. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol (2006); 48: 2508-2514.
52. Selwyn AP, Allan RM, L'Abbate A, Horlock P, Camici P, Clark J, O'Brien HA, Grant PM. Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia. Am J Cardiol (1982); 50: 112-121.
53. Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, Sgouros G, Bengel FM. Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med (2010); 51: 1592-1599.
54. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol (2004); 11: 171-185.
55. Sheikine Y, Di Carli MF. Integrated PET/CT in the assessment of etiology and viability in ischemic heart failure. Curr Heart Fail Rep (2008); 5: 136-142.
56. Storto G, Soricelli A, Pellegrino T, Petretta M, Cuocolo A. Assessment of the arterial input function for estimation of coronary flow reserve by single photon emission computed tomography: comparison of two different approaches. Eur J Nucl Med Mol Imaging (2009); 36: 2034-2041.
57. Tamaki N, Yonekura Y, Senda M, Yamashita K, Koide H, Saji H, Hashimoto T, Fudo T, Kambara H, Kawai C, Konishi J., et al. Value and limitation of stress thallium-201 single photon emission computed tomography: comparison with nitrogen-13 ammonia positron tomography. J Nucl Med (1988); 29: 1181-1188.
58. Thompson RC, Cullom SJ. Issues regarding radiation dosage of cardiac nuclear and radiography procedures. J Nucl Cardiol (2006); 13: 19-23.
59. Venkataraman R, Hage FG, Dorfman T, Heo J, Aqel RA, de Mattos AM, Iskandrian AE. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. Am J Cardiol (2008); 102: 1451-1456.
60. Walsh MN, Bergmann SR, Steele RL, Kenzora JL, Ter-Pogossian MM, Sobel BE, Geltman EM. Delineation of impaired regional myocardial perfusion by positron emission tomography with H2(15)O. Circulation (1988); 78: 612-620.
61. van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Boersma E, Wijns W, Stolzmann P, Alkadhi H, Valenta I, Stokkel MP, Kroft LJ, de Roos A, Pundziute G, Scholte A, van der Wall EE, Kaufmann PA, Bax JJ. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol (2009); 53: 623-632.
62. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J (2010); 31: 2501-2555.
63. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med (1996); 37: 1701-1712.
64. Zaret BL, Cohen LS. Cardiovascular nuclear medicine II: evaluation of perfusion and viability. Mod Concepts Cardiovasc Dis (1977); 46: 37-42.